BETHESDA, MD -- 07/16/08 --
The Parenteral Drug Association (PDA)
announced today that together with the US Food and Drug Administration (US
FDA), it will host the PDA/FDA Pharmaceutical Ingredient Supply Chain
Conference in Washington, D.C., September 10-12, 2008. The program is being
developed jointly with FDA and will provide information on guidance and
regulations from around the world, including North America, Europe and
Asia. Presenters from the World Health Organization (WHO), the US
Pharmacopeia (USP), FDA, the Shanghai Food and Drug Administration (SHFDA)
as well as industry experts, will share their perspectives and solutions
during eight sessions.
"We are pleased to work with FDA to offer this timely conference," said
Robert Myers, PDA President. "As the pharmaceutical industry continues to
globalize, ensuring the quality and safety of products to the patient has
become increasingly more challenging. This conference will help to that end
by addressing global initiatives to assure the integrity of the
pharmaceutical ingredient supply chain."
Session topics will cover: challenges in ensuring the quality and integrity
of pharmaceutical ingredients; regulations and guidance on Good
Manufacturing Practices (GMPs) and Good Distribution Practices (GDPs); the
role of quality systems in supply chain operations; industry practices; and
opportunities for global cooperation, collaboration and harmonization.
Full conference details are available at www.pda.org/supplychain.
About PDA
Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is a nonprofit international
organization and a leading global provider of science, technology, and
regulatory information and education for the pharmaceutical and
biopharmaceutical community. PDA is committed to developing scientifically
sound, practical technical information and resources to advance science and
regulation through the expertise of its more than 11,000 members worldwide.
More information about PDA is available at www.pda.org.
Contact:
Diana Kaminsky
Email Contact
Tel: +1 (301) 656-5900, ext. 145
